BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31727231)

  • 1. Comorbid depression and apathy in HIV-associated neurocognitive disorders in the era of chronic HIV infection.
    Cysique LA; Brew BJ
    Handb Clin Neurol; 2019; 165():71-82. PubMed ID: 31727231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression and Apathy Among People Living with HIV: Implications for Treatment of HIV Associated Neurocognitive Disorders.
    Bryant VE; Whitehead NE; Burrell LE; Dotson VM; Cook RL; Malloy P; Devlin K; Cohen RA
    AIDS Behav; 2015 Aug; 19(8):1430-7. PubMed ID: 25533921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric symptom burden in older people living with HIV with and without cognitive impairment: the UCSF HIV over 60 cohort study.
    Milanini B; Catella S; Perkovich B; Esmaeili-Firidouni P; Wendelken L; Paul R; Greene M; Ketelle R; Valcour V
    AIDS Care; 2017 Sep; 29(9):1178-1185. PubMed ID: 28127989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV Infection and Neurocognitive Disorders in the Context of Chronic Drug Abuse: Evidence for Divergent Findings Dependent upon Prior Drug History.
    Illenberger JM; Harrod SB; Mactutus CF; McLaurin KA; Kallianpur A; Booze RM
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):715-728. PubMed ID: 32533296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychiatric Disorders, Emotional Disturbances, and Their Associations with HIV-Associated Neurocognitive Disorder.
    Muñoz-Moreno JA; Cysique LA; Rourke SB
    Curr Top Behav Neurosci; 2021; 50():347-366. PubMed ID: 34081306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HIV infection and depression].
    Mertens A
    MMW Fortschr Med; 2014 Jun; 156 Suppl 1():15-8. PubMed ID: 25026849
    [No Abstract]   [Full Text] [Related]  

  • 7. Apathy associated with neurocognitive disorders: Recent progress and future directions.
    Lanctôt KL; Agüera-Ortiz L; Brodaty H; Francis PT; Geda YE; Ismail Z; Marshall GA; Mortby ME; Onyike CU; Padala PR; Politis AM; Rosenberg PB; Siegel E; Sultzer DL; Abraham EH
    Alzheimers Dement; 2017 Jan; 13(1):84-100. PubMed ID: 27362291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between Depressive Symptomatology and Neurocognitive Impairment in HIV/AIDS.
    Tymchuk S; Gomez D; Koenig N; Gill MJ; Fujiwara E; Power C
    Can J Psychiatry; 2018 May; 63(5):329-336. PubMed ID: 29228820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurologic Changes and Depression.
    Greene RD; Wang S
    Psychiatr Clin North Am; 2018 Mar; 41(1):111-126. PubMed ID: 29412840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychiatric comorbidity in depressed HIV-infected individuals: common and clinically consequential.
    Gaynes BN; O'Donnell J; Nelson E; Heine A; Zinski A; Edwards M; McGuinness T; Riddhi MA; Montgomery C; Pence BW
    Gen Hosp Psychiatry; 2015; 37(4):277-82. PubMed ID: 25892152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-associated neurocognitive disorder.
    Clifford DB
    Curr Opin Infect Dis; 2017 Feb; 30(1):117-122. PubMed ID: 27798498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive Reserve Over the Lifespan: Neurocognitive Implications for Aging With HIV.
    Vance DE; Lee L; Muñoz-Moreno JA; Morrison S; Overton T; Willig A; Fazeli PL
    J Assoc Nurses AIDS Care; 2019; 30(5):e109-e121. PubMed ID: 30865059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of treatment studies of depression in HIV.
    Olatunji BO; Mimiaga MJ; O'Cleirigh C; Safren SA
    Top HIV Med; 2006; 14(3):112-24. PubMed ID: 16946456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apathy in persons living with HIV disease: A systematic narrative review.
    Thompson JL; Woods SP; Medina LD; Garcia JM; Teixeira AL
    J Affect Disord; 2024 Apr; 350():133-147. PubMed ID: 38224740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships among apathy, depression, and cognitive impairment in HIV/AIDS.
    Rabkin JG; Ferrando SJ; van Gorp W; Rieppi R; McElhiney M; Sewell M
    J Neuropsychiatry Clin Neurosci; 2000; 12(4):451-7. PubMed ID: 11083161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review.
    Gates TM; Cysique LA
    CNS Drugs; 2016 Jan; 30(1):53-69. PubMed ID: 26749584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D deficiency is associated with neurocognitive impairment in HIV-infected subjects.
    Vergori A; Pinnetti C; Lorenzini P; Brita A; Libertone R; Mastrorosa I; Cicalini S; Antinori A; Ammassari A
    Infection; 2019 Dec; 47(6):929-935. PubMed ID: 31183805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What are the pharmacologic considerations when treating depression in patients with HIV infection?
    Swenson JR
    J Psychiatry Neurosci; 1998 May; 23(3):200. PubMed ID: 11499431
    [No Abstract]   [Full Text] [Related]  

  • 19. Reliability, validity, and clinical correlates of apathy in Parkinson's disease.
    Starkstein SE; Mayberg HS; Preziosi TJ; Andrezejewski P; Leiguarda R; Robinson RG
    J Neuropsychiatry Clin Neurosci; 1992; 4(2):134-9. PubMed ID: 1627973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong - a single center study.
    Chan FCC; Chan P; Chan I; Chan A; Tang THC; Lam W; Fong WC; Lee MP; Li P; Chan GHF
    BMC Infect Dis; 2019 Feb; 19(1):156. PubMed ID: 30760220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.